{"nct_id":"NCT03425643","title":"Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2018-04-24","start_date_type":"ACTUAL","primary_completion_date":"2023-07-10","primary_completion_date_type":"ACTUAL","completion_date":"2026-06-29","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}